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To the Editor: I read with great interest the letters by Wan
et al.1 and Garg.2
The authors discussed the possibility and consequences of
labeling former kidney donors with estimated GFR o60 ml
per min per 1.73 m2 as chronic kidney disease patients.
According to NKF K/DOQI guidelines that established the
current classification of chronic kidney disease, it is possible
that GFR 30–59 ml per min per 1.73 m2 could also be normal
in individuals after unilateral nephrectomy.3 Therefore
‘chronically decreased GFR’ could be the more appropriate
term to name the condition of these subjects in the absence of
any additional marker of kidney damage.
Both authors agree about the possibility of increased
cardiovascular risk in these patients and then emphasis
the need of research on the prognostic significance of a
reduced estimated GFR in this population. We recently
studied the frequency and severity of coronary artery
calcification in 101 former kidney donors to test the
hypothesis that decreased GFR is associated with increased
coronary artery calcification.4 The median post nephrectomy
duration was 64.7 months and mean GFR was 75 ml per min
per 1.73 m2. The frequency or severity of coronary artery
calcification was not increased in these former kidney donors.
These results could be at least partially reassuring the safety
of kidney donation in carefully selected donors. Certainly,
this reassurance should not shadow the importance of
healthy life style behavior and yearly regular follow-ups after
kidney donation.
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We welcome Dr Seyahi’s1 contribution to the uncertainty
surrounding the impact of mildly reduced kidney function
on future cardiovascular risk. This debate has been
generated by numerous large retrospective observational
studies. These studies are unable to determine if the
observed association between mildly reduced glomerular
filtration rate (GFR) and cardiovascular risk is causal or is
explained by comorbid conditions that lead to kidney
damage. Studies of living kidney donors offer an oppor-
tunity to test the hypothesis that reduced GFR directly
causes cardiovascular disease, because kidney donors
have an abrupt, isolated reduction in GFR in the absence
of other major comorbid illnesses or cardiovascular
risk factors. However, the low absolute cardiovascular
event rate in these subjects after nephrectomy means that
studies to adequately test the hypothesis will require large
cohorts, more than 10 years follow-up, and appropriate
selection of control subjects. In this respect, we are sure Dr
Seyahi will acknowledge that their data on 101 kidney
donors followed for a median of 5 years showing no
coronary calcification offer some reassurance, but do
not reject the hypothesis.
Counseling patients with mildly reduced GFR will
remain difficult until these uncertainties are clarified,
and we hope that Dr Seyahi’s research will stimulate others
to analyze cardiovascular risk in kidney donors.
In the meantime, the labels ‘chronically decreased GFR’
and ‘chronic kidney disease’ are likely to seem equally
imprecise and of concern to the patient with mildly
reduced GFR.
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As we promote living kidney donor transplantation as the
preferred treatment option for kidney failure, there is now
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